4.6 Article

EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Cell Biology

Transient Exposure of Endothelial Cells to Doxorubicin Leads to Long-Lasting Vascular Endothelial Growth Factor Receptor 2 Downregulation

Silvia Graziani et al.

Summary: Doxorubicin is an effective antineoplastic drug, but its serious cardiotoxic side effects can lead to heart failure. This study reveals that transient exposure to Doxorubicin can cause long-term downregulation of VEGFR2 in endothelial cells, which is essential for their function. The downregulation is not dependent on autophagy, but rather on Doxorubicin-induced p53 expression and inhibition of protein synthesis.
Article Biochemistry & Molecular Biology

Cardiovascular ramifications of therapy-induced endothelial cell senescence in cancer survivors

Ibrahim Y. Abdelgawad et al.

Summary: Therapy-induced senescence is a fundamental mechanism contributing to adverse health complications in cancer survivors. This mini-review focuses on the mechanisms of endothelial cell senescence and discusses novel senotherapeutic approaches.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)

Article Oncology

Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition

Masum Rahman et al.

MOLECULAR CANCER RESEARCH (2022)

Review Pharmacology & Pharmacy

Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span

Paul D. Robbins et al.

Summary: Senescence is a signaling mechanism activated in stressed cells to prevent proliferation of damaged cells, leading to chronic sterile inflammation and age-related diseases. Senescent cells accumulate with age and in diseased anatomical sites, making them a logical therapeutic target. Senotherapeutics, a new class of drugs, selectively kill senescent cells or suppress their disease-causing phenotypes, showing promising results in preclinical studies and clinical trials.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)

Review Cell Biology

Endothelial cell senescence: A machine learning-based meta-analysis of transcriptomic studies

Hyun Suk Park et al.

Summary: Through sophisticated machine learning algorithms, common features of endothelial cell senescence were identified, including 400 differentially expressed genes and 57 core pathways, with phosphoglycerate dehydrogenase and serine biosynthesis pathway showing significant association. The model performed well, indicating the potential of using meta-analysis to find consensus features of endothelial cell senescence.

AGEING RESEARCH REVIEWS (2021)

Article Geriatrics & Gerontology

Anti-SASP and anti-inflammatory activity of resveratrol, curcumin and β-caryophyllene association on human endothelial and monocytic cells

Giulia Matacchione et al.

Summary: The combination of three natural compounds has been shown to effectively reduce the expression levels of inflammatory factors in senescent cells, increase SIRT1 protein level, and decrease the expression levels of certain inflammation-related miRNAs, providing a more significant effect compared to using the compounds individually.

BIOGERONTOLOGY (2021)

Review Pharmacology & Pharmacy

Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence

Ibrahim Y. Abdelgawad et al.

Summary: Cancer treatment can accelerate aging and increase the risk of cardiovascular complications. While there are approaches to mitigate therapy-induced senescence, strategies to prevent and treat cardiovascular senescence have not yet been translated to clinical practice.

PHARMACOLOGY & THERAPEUTICS (2021)

Article Cell Biology

Impact of Senescent Cell Subtypes on Tissue Dysfunction and Repair: Importance and Research Questions

Utkarsh Tripathi et al.

Summary: Cellular senescence is a dynamic process with diverse functional characteristics that can be influenced by various factors. Understanding the background information about senescent cells is crucial for identifying rational therapeutic strategies.

MECHANISMS OF AGEING AND DEVELOPMENT (2021)

Article Multidisciplinary Sciences

Vitamin D3 attenuates doxorubicin-induced senescence of human aortic endothelial cells by upregulation of IL-10 via the pAMPKα/Sirt1/Foxo3a signaling pathway

Lei Chen et al.

Summary: The study found that vitamin D3 can significantly attenuate doxorubicin-induced damage to heart cells by modulating the activity of various protein complexes. This discovery helps in finding a target to mitigate doxorubicin-induced cardiovascular toxicity.

PLOS ONE (2021)

Article Pharmacology & Pharmacy

Vildagliptin improves vascular smooth muscle relaxation and decreases cellular senescence in the aorta of doxorubicin-treated rats

Svetozar Misuth et al.

Summary: The study suggests that vildagliptin treatment can reduce senescence and improve the relaxation of vascular smooth muscle in the aorta of rats treated with DOX. Additionally, GLP-1 can reduce senescence in DOX-treated VSMCs, indicating that incretin-based drugs may be promising for patients experiencing late doxorubicin cardiovascular toxicity.

VASCULAR PHARMACOLOGY (2021)

Article Biotechnology & Applied Microbiology

Differences between common endothelial cell models (primary human aortic endothelial cells and EA.hy926 cells) revealed through transcriptomics, bioinformatics, and functional analysis

Dongdong Wang et al.

Summary: This study identified 529 differentially expressed genes (DEGs) between primary human aortic ECs (HAECs) and immortal EA.hy926 cells. Enrichment analysis revealed that DEGs highly expressed in HAECs are involved in the Rap1 signaling pathway and Ras signaling pathway, contributing to endothelial barrier function and endocytosis. Furthermore, the study established ceRNA and protein-protein interaction networks, suggesting that HAECs show a stronger response to HDL binding and endocytosis compared to EA.hy926 cells.

CURRENT RESEARCH IN BIOTECHNOLOGY (2021)

Article Pharmacology & Pharmacy

Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway

Huan He et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Oncology

IL-6 promotes cell adhesion in human endothelial cells via microRNA-126-3p suppression

Momoka Ohta et al.

EXPERIMENTAL CELL RESEARCH (2020)

Article Medicine, Research & Experimental

The senescence-associated secretome as an indicator of age and medical risk

Marissa J. Schafer et al.

JCI INSIGHT (2020)

Review Cell Biology

Cell Senescence, Multiple Organelle Dysfunction and Atherosclerosis

Gisela Machado-Oliveira et al.

Article Oncology

Premature Aging in Young Cancer Survivors

Saro H. Armenian et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)

Article Biochemistry & Molecular Biology

Transcriptome signature of cellular senescence

Gabriel Casella et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Cell Biology

PAI-1 contributes to homocysteine-induced cellular senescence

Tianjiao Sun et al.

CELLULAR SIGNALLING (2019)

Review Medicine, Research & Experimental

Mechanisms and functions of cellular senescence

Nicolas Herranz et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Article Medicine, General & Internal

Fisetin is a senotherapeutic that extends health and lifespan

Matthew J. Yousefzadeh et al.

EBIOMEDICINE (2018)

Review Medicine, General & Internal

Cardiovascular disease in cancer survivors

Tochi M. Okwuosa et al.

POSTGRADUATE MEDICAL JOURNAL (2017)

Article Multidisciplinary Sciences

Techniques to Induce and Quantify Cellular Senescence

Nicole Noren Hooten et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)

Article Multidisciplinary Sciences

Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL

Reut Yosef et al.

NATURE COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Cellular senescence in aging and age-related disease: from mechanisms to therapy

Bennett G. Childs et al.

NATURE MEDICINE (2015)

Review Multidisciplinary Sciences

The role of senescent cells in ageing

Jan M. van Deursen

NATURE (2014)

Article Oncology

AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer

Luigi Moretti et al.

JOURNAL OF THORACIC ONCOLOGY (2010)

Article Oncology

ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor

Christin Tse et al.

CANCER RESEARCH (2008)